Abstract
Minicircle DNA (mcDNA) has been considered to be an alternative choice of traditional DNA vaccine due to its much smaller size, resulting in more efficient antigen synthesis, enhanced and long-lasting adaptive immune response, especially cellular immune response. However, the disadvantages such as relative high cost and labor intensiveness severely restrict its direct application in the field of veterinary vaccine. Here, we describe a novel Cre Recombinase-mediated In vivo McDNA platform, named CRIM, in which the parental plasmid could spontaneously transform into mcDNA by itself after transfection or oral administration. This CRIM vaccine platform might serve as a novel oral antigen delivery system for any infectious diseases, especially for veterinary application.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Heppell J, Davis HL (2000) Application of DNA vaccine technology to aquaculture. Adv Drug Deliv Rev 43:29–43
Davis BS, Chang GJ, Cropp B et al (2001) West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J Virol 75:4040–4047
Garver KA, LaPatra SE, Kurath G (2005) Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon. Dis Aquat Org 64:13–22
Bergman PJ, Camps-Palau MA, McKnight JA et al (2006) Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the animal medical center. Vaccine 24:4582–4585
Draghia-Akli R, Ellis KM, Hill LA et al (2003) High-efficiency growth hormone-releasing hormone plasmid vector administration into skeletal muscle mediated by electroporation in pigs. FASEB J 17:526–528
Jiang Y, Yu K, Zhang H et al (2007) Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector. Antivir Res 75:234–241
Li L, Saade F, Petrovsky N (2012) The future of human DNA vaccines. J Biotechnol 162:171–182
Munye MM, Tagalakis AD, Barnes JL et al (2016) Minicircle DNA provides enhanced and prolonged transgene expression following airway gene transfer. Sci Rep 6:23125
Tolmachov O, Palaszewski I, Bigger B et al (2006) RecET driven chromosomal gene targeting to generate a RecA deficient Escherichia coli strain for Cre mediated production of minicircle DNA. BMC Biotechnol 6:17
Simcikova M, Alves CPA, Brito L et al (2016) Improvement of DNA minicircle production by optimization of the secondary structure of the 5′-UTR of ParA resolvase. Appl Microbiol Biotechnol 100:6725–6737
Kay MA, He CY, Chen ZY (2010) A robust system for production of minicircle DNA vectors. Nat Biotechnol 28:1287–1289
Schleef M, Schirmbeck R, Reiser M et al (2015) Minicircle: next generation DNA vectors for vaccination. Methods Mol Biol 1317:327–339
Stenler S, Blomberg P, Smith CI (2014) Safety and efficacy of DNA vaccines: plasmids vs. minicircles. Hum Vaccin Immunother 10:1306–1308
Dietz WM, Skinner NE, Hamilton SE et al (2013) Minicircle DNA is superior to plasmid DNA in eliciting antigen-specific CD8+ T-cell responses. Mol Ther 21:1526–1535
Li F, Cheng L, Murphy CM et al (2016) Minicircle HBV cccDNA with a Gaussia luciferase reporter for investigating HBV cccDNA biology and developing cccDNA-targeting drugs. Sci Rep 6:36483
Wang Q, Jiang W, Chen Y et al (2014) In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses. J Virol 88:1924–1934
Jiang Y, Gao X, Xu K et al (2019) A novel Cre recombinase-mediated in vivo Minicircle DNA (CRIM) vaccine provides partial protection against Newcastle disease virus. Appl Environ Microbiol 85:e00407–e00419
Zhao Z, Xue Y, Wu B et al (2008) Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica. Infect Immun 76:2157–2163
Li MZ, Elledge SJ (2005) MAGIC, an in vivo genetic method for the rapid construction of recombinant DNA molecules. Nat Genet 37:311–319
Gregor Siebenkotten H, Christine R, Radbruch A (1995) Isolation of plasmid DNA from mammalian cells using QIAprep kit. QIAGEN News 2, page 11 2:2
Acknowledgments
This work was supported by the National Natural Science Foundation of China (31602092).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Jiang, Y., Yang, G., Wang, C. (2021). A Novel Cre Recombinase-Mediated In Vivo Minicircle (CRIM) DNA Vaccine Platform for Veterinary Application. In: Sousa, Â. (eds) DNA Vaccines. Methods in Molecular Biology, vol 2197. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0872-2_1
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0872-2_1
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0871-5
Online ISBN: 978-1-0716-0872-2
eBook Packages: Springer Protocols